利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

16 条记录 (耗时 0.016 秒)

    Depsipeptides and drugs containing the same as the active ingredient
    2.
    发明授权
    Depsipeptides and drugs containing the same as the active ingredient 有权
    含有与活性成分相同的多肽和药物

    公开(公告)号：US06255286B1

    公开(公告)日：2001-07-03

    申请号：US09214002

    申请日：1998-12-24

    申请人： Makoto Yanai ,  Masashi Suzuki ,  Norio Oshida ,  Koji Kawamura ,  Shigeru Hiramoto ,  Orie Yasuda ,  Nobuhiro Kinoshita ,  Akiko Shingai ,  Masako Takasu

    发明人： Makoto Yanai ,  Masashi Suzuki ,  Norio Oshida ,  Koji Kawamura ,  Shigeru Hiramoto ,  Orie Yasuda ,  Nobuhiro Kinoshita ,  Akiko Shingai ,  Masako Takasu

    IPC分类号： A61K3800

    CPC分类号： C07K5/1021 ,  A61K38/00 ,  C07K5/06043 ,  C07K5/06052 ,  C07K5/06104 ,  C07K5/101 ,  C07K7/06 ,  C07K11/00

    摘要： Depsipeptides represented by the formula (1): (wherein: R1 is a straight or branched alkyl group of 5-20 carbon atoms or a straight or branched alkoxymethyl group of 5-15 carbon atoms; R2 is —A—B, —A—B—W, —A—B—W—D or —A—B—W—D—E, R3 is a hydroxyl group, a lower alkoxy group, a benzyloxy group, —Z, —Z—G or —Z—G—J, the above A, B, D, E, G and J independently each other are a residue of an amino acid selected from alanine, valine, leucine, isoleucine, serine, threonine, lysine, hydroxylysine, arginine, cysteine, methionine, phenylalanine, tyrosine, aspartic acid, asparagine, glutamic acid, glutamine and the like or an N—(C1-C4) alkyl derivative of these amino acid residues; the above W and Z independently each other are a residue of an amino acid selected from aspartic acid, asparagine, glutamic acid, glutamine, alanine, serine or lysine) or pharmacologically acceptable salts thereof. The depsipeptides have an activity of promoting the production of apolipoprotein E and are useful as a therapeutic agent for neurologic damages, especially for dementia, and further as a therapeutic agent for hyperlipemia.

    摘要翻译： 由式（1）表示的缩肽：其中：R1是5-20个碳原子的直链或支链烷基或5-15个碳原子的直链或支链烷氧基甲基; R2是-AB，-ABW，-ABWD 或-ABWDE，R3是羟基，低级烷氧基，苄氧基，-Z，-ZG或-ZGJ，上述A，B，D，E，G和J彼此独立地是氨基的残基 选自丙氨酸，缬氨酸，亮氨酸，异亮氨酸，丝氨酸，苏氨酸，赖氨酸，羟赖氨酸，精氨酸，半胱氨酸，甲硫氨酸，苯丙氨酸，酪氨酸，天冬氨酸，天冬酰胺，谷氨酸，谷氨酰胺等的N-酸或N-（C1-C4） 这些氨基酸残基的烷基衍生物;上述W和Z彼此独立地是选自天冬氨酸，天冬酰胺，谷氨酸，谷氨酰胺，丙氨酸，丝氨酸或赖氨酸的氨基酸的残基）或其药理学上可接受的盐。脱脂肽具有 促进载脂蛋白E的产生的活性并且可用作治疗 用于神经损伤的特异剂，特别是对于痴呆，并且作为高脂血症的治疗剂。

    FAT ABSORPTION INHIBITORY COMPOSITION
    3.
    发明申请
    FAT ABSORPTION INHIBITORY COMPOSITION 审中-公开
    脂肪吸收抑制组合物

    公开(公告)号：US20100173025A1

    公开(公告)日：2010-07-08

    申请号：US12676321

    申请日：2008-09-04

    申请人： Yuki Katayanagi ,  Shigeru Hiramoto

    发明人： Yuki Katayanagi ,  Shigeru Hiramoto

    IPC分类号： A61K36/899 ,  A61P3/04 ,  A61P3/06 ,  A61P9/12 ,  A61P3/10

    CPC分类号： A21D2/38 ,  A23L7/152 ,  A23L23/00 ,  A23L33/105 ,  A23V2002/00 ,  A61K36/899 ,  A23V2200/332

    摘要： The present invention provides a composition that exhibits favorable fat absorption inhibitory activity, is capable of being safely and easily taken continuously without side effects, and further is capable of preventing and/or improving conditions associated with excessive fat absorption such as obesity and hyperlipidemia. The present invention relates to a fat absorption inhibitory composition, which contains as an active ingredient a component that is collected as insoluble matter obtained by extracting wheat germ with water at 65° C. or lower and pH 5.0 or lower and treating the extract at 70° C. or higher and pH 6.0 or higher.

    摘要翻译： 本发明提供一种具有良好的吸脂抑制活性的组合物，能够连续不间断地连续使用而不发生副作用，并且能够预防和/或改善与过量脂肪吸收相关的症状，例如肥胖症和高脂血症。 本发明涉及一种脂肪吸收抑制组合物，其含有作为活性成分的成分，作为不溶物收集，所述成分是通过在65℃以下且pH5.0以下的水中提取小麦胚芽而获得的， ℃以上且pH6.0以上。

    Cyclic depsipeptides and drugs containing the same as the active ingredient
    4.
    发明授权
    Cyclic depsipeptides and drugs containing the same as the active ingredient 失效
    循环利肽和含有与活性成分相同的药物

    公开(公告)号：US06858585B1

    公开(公告)日：2005-02-22

    申请号：US09147434

    申请日：1997-06-25

    申请人： Makoto Yanai ,  Masashi Suzuki ,  Norio Oshida ,  Koji Kawamura ,  Shigeru Hiramoto ,  Orie Yasuda ,  Nobuhiro Kinoshita ,  Akiko Shingai ,  Masako Takasu

    发明人： Makoto Yanai ,  Masashi Suzuki ,  Norio Oshida ,  Koji Kawamura ,  Shigeru Hiramoto ,  Orie Yasuda ,  Nobuhiro Kinoshita ,  Akiko Shingai ,  Masako Takasu

    IPC分类号： A61K38/00 ,  C07K7/06 ,  A61K38/15 ,  C07K7/00

    CPC分类号： C07K7/06 ,  A61K38/00

    摘要： Cyclic depsipeptides represented by the formula wherein: R is a straight or branched alkyl group of 5-20 carbon atoms or a straight or branched alkoxymethyl group of 5-15-carbon atoms; A, B, D, E and F independently each other are alanine, valine, leucine, isoleucine, phenylalanine, etc.; W and Z independently each other are aspartic acid, asparagine, glutamic acid or glutamine; and m and n independently each other is 0 or 1, or pharmacologically acceptable salts thereof. The present compounds are prepared according to a method conventionally used in peptide synthesis. The present compounds are useful as an agent for promoting the production of apolipoprotein E, a therapeutic agent for neurologic damages, a therapeutic agent for dementia, an agent for inhibiting the production of apolipoprotein B, an agent for promoting the production of apolipoprotein A1 or a therapeutic agent for hyperlipemia.

    摘要翻译： 以下式表示的环状缩酚酸酯：R为5-20个碳原子的直链或支链烷基或5-15个碳原子的直链或支链烷氧基甲基; A，B，D，E和F独立地为丙氨酸，缬氨酸，亮氨酸，异亮氨酸，苯丙氨酸等; W和Z独立地是天冬氨酸，天冬酰胺，谷氨酸或谷氨酰胺; m和n彼此独立地为0或1，或其药理学上可接受的盐。 本发明化合物根据肽合成中常规使用的方法制备。 本发明化合物可用作促进载脂蛋白E的产生，神经损伤治疗剂，痴呆治疗剂，抑制载脂蛋白B的制备的试剂，促进载脂蛋白A1的制造的试剂或 高脂血症治疗剂。

    Bicyclic depsipeptides
    5.
    发明授权
    Bicyclic depsipeptides 失效
    双环脱肽

    公开(公告)号：US06211145B1

    公开(公告)日：2001-04-03

    申请号：US09212481

    申请日：1998-12-16

    申请人： Makoto Yanai ,  Masashi Suzuki ,  Norio Oshida ,  Koji Kawamura ,  Shigeru Hiramoto ,  Orie Yasuda ,  Nobuhiro Kinoshita ,  Akiko Shingai ,  Masako Takasu

    发明人： Makoto Yanai ,  Masashi Suzuki ,  Norio Oshida ,  Koji Kawamura ,  Shigeru Hiramoto ,  Orie Yasuda ,  Nobuhiro Kinoshita ,  Akiko Shingai ,  Masako Takasu

    IPC分类号： A61K3808

    CPC分类号： C07K7/06 ,  A61K38/00 ,  C07K7/56 ,  C07K7/64

    摘要： The present invention provides a bicyclic depsipeptide having the formula (1) wherein: R is a straight or branched alkyl group of 5-20 carbon atoms or a straight or branched alkoxymethyl group of 5-15 carbon atoms; A, D, E and J independently are a residue of an amino acid selected from the group of alanine, valine, leucine, etc.; B and F are the same or different and a residue of an amino acid selected from the group consisting of cysteine, aspartic acid, glutamic acid, lysine, hydroxylysine and serine; G is a disulfide bond, an amido bond or an ester bond; W is a residue of an amino acid selected from the group consisting of aspartic acid and glutamic acid; Z is a residue of an amino acid selected from the group consisting of aspartic acid, asparagine, glutamic acid and glutamine; l, m, n, p and q independently are 0 or 1; or a pharmacologically acceptable salt thereof.

    摘要翻译： 本发明提供具有式（1）的双环脱肽酶，其中：R是5-20个碳原子的直链或支链烷基或5-15个碳原子的直链或支链烷氧基甲基; A，D，E和J独立地是选自丙氨酸，缬氨酸，亮氨酸等的氨基酸的残基; B和F相同或不同，并且选自半胱氨酸，天冬氨酸，谷氨酸，赖氨酸，羟赖氨酸和丝氨酸的氨基酸残基; G是二硫键，酰胺键或酯键; W是选自天冬氨酸和谷氨酸的氨基酸残基; Z是选自天冬氨酸，天冬酰胺，谷氨酸和谷氨酰胺的氨基酸的残基; l，m，n，p和q独立地为0或1; 或其药理学上可接受的盐。

    Cyclic depsipeptides useful for treatment of hyperlipemia
    8.
    发明授权
    Cyclic depsipeptides useful for treatment of hyperlipemia 失效
    用于治疗高脂血症的循环利肽

    公开(公告)号：US5801143A

    公开(公告)日：1998-09-01

    申请号：US737599

    申请日：1996-11-25

    申请人： Shigeru Hiramoto ,  Yukio Saito ,  Shigeo Hatanaka ,  Akiko Shingai

    发明人： Shigeru Hiramoto ,  Yukio Saito ,  Shigeo Hatanaka ,  Akiko Shingai

    IPC分类号： A61K38/00 ,  C07K7/06 ,  C07K11/00 ,  A61K38/08 ,  A61K38/15 ,  C07K7/00

    CPC分类号： C07K7/06 ,  A61K38/00

    摘要： A cyclic depsipeptide having the general formula (I) ##STR1## (wherein n is an integer of 5-15) or a pharmacologically acceptable salt thereof. The present compound can be prepared by cultivation of a cyclic depsipeptide-producing microorganism belonging to the genus of Bacillus. The present compounds are useful as a therapeutic agent for hyperlipemia, an agent for inhibiting the secretion of lipids or an agent for inhibiting the production of apolipoprotein B.

    摘要翻译： PCT No.PCT / JP95 / 01003 Sec。 371日期：1996年11月25日 102（e）日期1996年11月25日PCT提交1995年5月25日PCT公布。 WO95 / 32990 PCT公开 日期：1995年12月7日具有通式（I）的缩水甘油肽（其中n为5-15的整数）或其药理学上可接受的盐。 本发明化合物可以通过培养属于芽孢杆菌属的环状来肽肽生产微生物来制备。 本发明化合物可用作高脂血症的治疗剂，抑制脂质分泌的药剂或抑制载脂蛋白B的产生的药剂。